Syndax Pharmaceuticals (1T3.F) Q2 2026 Earnings

Apr 30Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-1.11
-0.87
-0.64
-0.41

Details

Expected EPS
-0.5179938479999999
Actual EPS
-0.40910399999999997
Surprise EPS
0.11
Surprise Percent
+21.02%

Description

⁨Syndax Pharmaceuticals⁩ (⁦1T3.F⁩) has reported earnings of ⁦-0.40910399999999997⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts